142 related articles for article (PubMed ID: 8855226)
1. Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling.
Rühmann A; Köpke AK; Dautzenberg FM; Spiess J
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10609-13. PubMed ID: 8855226
[TBL] [Abstract][Full Text] [Related]
2. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
Bonk I; Rühmann A
Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
[TBL] [Abstract][Full Text] [Related]
3. Development of a selective photoactivatable antagonist for corticotropin-releasing factor receptor, type 2 (CRF2).
Bonk I; Rühmann A
Eur J Biochem; 2002 Nov; 269(21):5288-94. PubMed ID: 12392562
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
Rühmann A; Bonk I; Lin CR; Rosenfeld MG; Spiess J
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15264-9. PubMed ID: 9860957
[TBL] [Abstract][Full Text] [Related]
6. High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1.
Rühmann A; Bonk I; Köpke AK
Peptides; 1999 Nov; 20(11):1311-9. PubMed ID: 10612445
[TBL] [Abstract][Full Text] [Related]
7. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
[TBL] [Abstract][Full Text] [Related]
8. The brain corticotropin-releasing factor (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross-linking studies.
Grigoriadis DE; De Souza EB
J Biol Chem; 1988 Aug; 263(22):10927-31. PubMed ID: 2839512
[TBL] [Abstract][Full Text] [Related]
9. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.
Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
Dieterich KD; Grigoriadis DE; De Souza EB
Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
[TBL] [Abstract][Full Text] [Related]
12. The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding.
Sydow S; Flaccus A; Fischer A; Spiess J
Eur J Biochem; 1999 Jan; 259(1-2):55-62. PubMed ID: 9914475
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a sheep brain corticotropin releasing factor binding protein.
Behan DP; Cepoi D; Fischer WH; Park M; Sutton S; Lowry PJ; Vale WW
Brain Res; 1996 Feb; 709(2):265-74. PubMed ID: 8833763
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing factor (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization.
Grigoriadis DE; De Souza EB
Peptides; 1989; 10(1):179-88. PubMed ID: 2546128
[TBL] [Abstract][Full Text] [Related]
15. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
[TBL] [Abstract][Full Text] [Related]
16. Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor.
Sydow S; Radulovic J; Dautzenberg FM; Spiess J
Brain Res Mol Brain Res; 1997 Dec; 52(2):182-93. PubMed ID: 9495539
[TBL] [Abstract][Full Text] [Related]
17. Homologous desensitization of human corticotropin-releasing factor1 receptor in stable transfected mouse fibroblast cells.
Dieterich KD; Grigoriadis DE; De Souza EB
Brain Res; 1996 Feb; 710(1-2):287-92. PubMed ID: 8963673
[TBL] [Abstract][Full Text] [Related]
18. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
[TBL] [Abstract][Full Text] [Related]
19. Characterization of corticotropin-releasing factor receptors in dissociated brain cell cultures.
Kapcala LP; De Souza EB
Brain Res; 1988 Jul; 456(1):159-67. PubMed ID: 2842000
[TBL] [Abstract][Full Text] [Related]
20. Functional corticotropin-releasing factor receptors in human neuroblastoma cells.
Dieterich KD; DeSouza EB
Brain Res; 1996 Sep; 733(1):113-8. PubMed ID: 8891255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
